CVS raises transparency in beauty marketing
CVS Health is bringing more transparency to beauty care marketing with the introduction of the CVS Beauty Mark, a watermark highlighting imagery that hasn’t been materially altered.
Business
Sam’s Club to shut 63 stores
Sam’s Club plans to close 63 of its U.S. outlets in the next few weeks. The Walmart warehouse club chain said Thursday that the move will leave it with 597 locations, most of which also house pharmacies.
Jean Coutu retail network sales climb in 3Q
Retail network sales rose in the fiscal 2018 third quarter at the Jean Coutu Group, which posted declined corporate sales and earnings. On Thursday, the company also reaffirmed the closing timetable for its acquisition by Canadian food and drug retailer Metro Inc. The $4.
Business guru Jim Collins to speak at NACDS Annual Meeting
The National Association of Chain Drug Stores has tabbed best-selling author and business consultant Jim Collins as a keynote speaker for the 2018 NACDS Annual Meeting.
Sam’s Club health chief Jill Turner-Mitchael to retire
Jill Turner-Mitchael, senior vice president and general merchandise manager for consumables and health and wellness at Sam’s Club, is retiring. A Sam’s Club spokeswoman confirmed that Turner-Mitchael plans to retire at the end of the fiscal year.
Markwins Beauty Brands tabs Stefano Curti as global president
Veteran consumer health and beauty executive Stefano Curti has joined Markwins Beauty Brands as global president. Markwins said Tuesday that Curti assumed the new post effective Jan. 3.
Effort to build ‘new Rite Aid’ under way
There’s a “new Rite Aid” taking shape that executives say will emerge as a smaller but stronger company. Rite Aid Corp. president and chief operating officer Kermit Crawford said he’s confident the company “will succeed in building the new Rite Aid” following its $4.
Target tallies stronger-than-expected holiday sales
Target Corp. said holiday sales rose more than forecast, with sales at stores open at least a year climbing 3.4% in November and December. Target holiday sales and traffic were higher both in stores and online during the period, the discount store retailer reported Tuesday.
Diplomat CEO Phil Hagerman to retire
Phil Hagerman, co-founder, chairman and chief executive officer of Diplomat Pharmacy Inc., the nation’s largest independent specialty pharmacy, plans to retire.
CVS Health gives update on 2018 outlook
In an update for investors, CVS Health executives expressed confidence in its growth outlook and noted that the recently passed tax overhaul package should boost its cash flow by an estimated $1.2 billion.
Sales surge in 1Q at Walgreens Boots Alliance
Strong sales gains by the U.S. retail pharmacy division propelled Walgreens Boots Alliance (WBA) in its fiscal 2018 first quarter, which also saw the company exceed Wall Street’s earnings forecast. WBA said Thursday that, for the quarter ended Nov. 30, sales totaled $30.74 billion, up 7.
Rite Aid edges above Wall Street’s forecast for 3Q
Rite Aid Corp. topped Wall Street’s earnings projections for its fiscal 2018 third quarter, in which the company proceeded with the transfer of stores under its $4.375 billion asset sale to Walgreens Boots Alliance (WBA). Rite Aid said late Wednesday that for the quarter ended Dec.
Diplomat wraps up acquisition of LDI
Diplomat Pharmacy Inc. has closed its $595 million acquisition of pharmacy benefit manager LDI Integrated Pharmacy Services. With the completion of the cash-and-stock deal, Diplomat also announced that it has obtained $800 million in senior secured credit facilities.
Clavis Insight acquired by Ascential
Clavis Insight, an e-commerce specialist serving product manufacturers, is being acquired by Ascential plc, an international, business-to-business information company. Financial terms of the agreement weren’t disclosed.
Holiday retail sales rise for drug chains
Chain drug store holiday sales bettered last year’s results, with total dollar volume rising more than 4%.
WBA scales back stake in China joint venture
Walgreens Boots Alliance (WBA) plans to reduce its interest in Guangzhou Pharmaceuticals Corp., a pharmaceutical wholesale joint venture in China. WBA said Friday that, under the agreement, it will sell a 30% stake in Guangzhou Pharmaceuticals to Guangzhou Baiyunshan Pharmaceutical Holdings.